Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction

Circulation

Volumn 94, Issue 11, 1996, Pages 2735-2742

  Dakik, Habib Abbas ^a   Mahmarian, John J ^a   Kimball, Kay T ^a   Koutelou, Maria G ^a   Medrano, Rafael ^a   Verani, Mario S ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

myocardial infarction; prognosis; thrombolysis; tomography

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TOMOGRAPHY;

EID: 0029845302     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2735     Document Type: Article

References (32)

1. Gibson RS, Taylor GJ, Watson DD, Stebbins PT, Martin RP, Crampton RS, Beller GA, Predicting the extent and location of coronary artery disease during the early post infarction period by quantitative thallium-201 scinligraphy. Am J Cardiol. 1981;47:1010-1019.
2. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983;68:321-336.
3. Gibson RS, Beller GA, Gheorghiade M, Nygaard TW, Watson DD, Huey BL, Sayre SL, Kaiser DL. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. Circulation. 1986;73:1186-1198.
4. Brown KA, Weiss RM, Clements JP, Wackers FJ. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardial. 1987;60:15-19.
5. Gruppo Italiano per lo studio della streptochinasi nell'infaito miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
6. Gruppo Italiano per lo studio della streptochinasi nell'infarto miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI Study. Lancet. 1987;2:871-874.
7. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-585.
8. White HD, Morris KM, Brown MA, Takayama M, Maslowski A, Bass NM, Ormiston JA, Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987;317:850-855.
9. ISIS 2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1987;2:349-360.
10. Mahmarian JJ, Pratt CM, Borges-Neto S, Cushion WR, Roberts R, Verani MS. Quantification of infarct size by thallium-201 single-photon emission computed tomography during acute myocardial infarction in man: comparison with enzymatic estimates. Circulation. 1988;78:831-839.
11. Brace R, Hornsten T. Exercise stress testing in the evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969;11:371-390.
12. Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative thallium-201 single-photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol. 1990;15:318-329.
13. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811-818.
14. Lee ET. Statistical Methods for Survival Data Analysis. 2nd ed. Belmont, Calif: Lifetime Learning Publications; 1992.
15. Stata Corporation. Stata Reference Manual: Release 3.1. 6th ed. College Station, Tex: Stata Corp; 1993.
16. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) phase II trial. N Engl J Med. 1989;320:618-627.
17. Gimple LW, Hutter AM, Guiney TE, Boucher CA. Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol. 1989;64:1243-1248.
18. Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee WW, Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med. 1984;310:1014-1018.
19. Wilson WW, Gibson RS, Nygaard TW, Craddock GB Jr, Watson DD, Crampton RS, Beller GA. Acute myocardial infarction associated with single vessel coronary artery disease: an analysis of clinical outcome and the prognostic importance of vessel patency and residual ischmiv myocardium. J Am Coll Cardiol. 1988;11:223-234.
20. Brown KA, O'Meara J, Chambres CE, Plante DA. Ability of dipyridamole-thallium-201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol. 1990;65:160-167.
21. Tilkemeier PL, Guiney TE, LaRaia PJ, Boucher CA. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction. Am J Cardiol. 1990;66:1203-1207.
22. Haber HL, Beller GA, Watson DD, Gimple LW. Exercise thallium-201 scintigraphy after thrombolytic therapy with or without angioplasty for acute myocardial infarction. Am J Cardiol. 1993;71:1257-1261.
23. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for denning long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol. 1995;25:133-140.
24. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R. One-year results of the Thrombolysis In Myocardial Infarction investigation (TIMI) phase II trial. Circulation. 1992;85:533-542.
25. Chaitman BR, McMahon RP, Terrin M, Younis LT, Shaw LJ, Weiner DA, Frederick MM, Knatterud GL, Sopko G, Braunwald E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis In Myocardial Infarction (TIMI) II trial. Am J Cardiol. 1993;71:131-138.
26. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol. 1993;22:665-670.
27. Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long-term survival in 618 patients from the Western Washington Streptokinase In Myocardial Infarction Trials. J Am Coll Cardiol. 1992;20:1452-1459.
28. Miller TD, Gersh BJ, Christian TF, Bailey KR, Gibbons RJ. Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis. Am Heart J. 1995;130:259-266.
29. The Multicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
30. Simoons ML, Vos J, Tijssen JGP, Vermeer F, Verheugt FWA, Krauss XH, Cats VM. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the interuniversity cardiology institute of the Netherlands. J Am Coll Cardiol. 1989;14:1609-1615.
31. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE, Sutherland W, Pilote L, Armstrong PW. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130-1135.
32. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ. Regional variation across the United States in the management of acute myocardial infarction: GUSTO-1 investigators - Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries. N Engl J Med. 1995;333:565-572.